Skip to content

Drug interactions

Sparsentan + Zafirlukast

Severity: Moderate

Sparsentan and Zafirlukast: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sparsentan can induce CYP2C9, and zafirlukast is partly cleared by this enzyme. Zafirlukast exposure may fall, potentially reducing asthma control.

What this interaction means in plain words

Sparsentan and Zafirlukast can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Sparsentan belongs to Genitourinary; Zafirlukast belongs to Respiratory.

Evidence level: Low

Why it happens

Sparsentan induces CYP2C9, increasing zafirlukast metabolism.

What to do

Monitor asthma symptoms after starting sparsentan. Consider alternative or additional controller therapy if control worsens.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Sparsentan and Zafirlukast, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Sparsentan with Zafirlukast?

MediHelp rates the interaction as moderate. Sparsentan and Zafirlukast can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sparsentan can induce CYP2C9, and zafirlukast is partly cleared by this enzyme. Zafirlukast exposure may fall, potentially reducing asthma control.

How serious is the interaction between Sparsentan and Zafirlukast?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor asthma symptoms after starting sparsentan. Consider alternative or additional controller therapy if control worsens.

What other medicines interact with Zafirlukast?

MediHelp also lists interactions of Zafirlukast with, for example, Pimozide, Lomitapide, Nilotinib. The full list is on the Zafirlukast page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in